Abilia Acquires Epilepsy Control Firm Livassured

Abilia, an assistive technology company, has acquired Livassured, a Dutch medtech firm specializing in epilepsy management, according to Medtech Magazine. Livassured, based in Leiden, generates approximately €4 million in annual revenue and employs around 15 people. The company is recognized for its Nightwatch device, a medical device engineered to detect epileptic seizures. The acquisition's financial details include an initial cash payment of €9.5 million and a deferred payment of €0.5 million for all shares. Additionally, the agreement stipulates a potential earn-out payment of up to €4 million, contingent upon Livassured's gross profit growth in 2026. This acquisition represents a significant development within the medtech industry, particularly in the epilepsy management sector.